A case of nephrocalcinosis in a 7-month-old with congenital hypothyroidism: Insights from targeted exome sequencing

Abstract

Nephrocalcinosis is a complex disease with a multitude of triggering factors. An association with congenital hypothyroidism has been described in the literature, but the mechanisms leading to its development remain unclear. A 7-month-old infant presented with muscular hypotonia and signs of malnutrition was diagnosed with congenital hypothyroidism, nephrocalcinosis of unclear origin, and multiple kidney stones. Urine analysis revealed the presence of calcium oxalate crystals and slightly elevated oxaluria without hypercalciuria. Targeted exome sequencing found no variants in the four causative genes of primary oxaluria, namely AGXT, CBX5, GRHPR, and HOGA1. The clinical outcome was favorable with thyroid hormone and potassium citrate treatment. Ultrasound follow-up showed progressive improvement of nephrocalcinosis. The low level of urinary oxalate and the prevalence of dihydrate calcium oxalate crystals spoke against primary or secondary oxaluria. Recent evidence from mitochondrial research shows that thyroid hormone T3 enhances mitochondrial calcium levels by stimulating calcium uptake by the mitochondrial calcium uniporter. A reduced calcium uptake and metabolism in mitochondria might represent an explanation for cytoplasmic calcium accumulation in tubular cells, subsequently precipitating nephrocalcinosis in the absence of thyroid hormone. Even if the pathophysiological mechanisms are not yet fully understood, recent evidence is supportive of a causal relationship between hypothyroidism and nephrocalcinosis, a sometimes overlooked association.

Keywords

congenital hypothyroidism / hyperoxaluria / nephrocalcinosis / targeted exome sequencing

References

[1] Newman RJ. The effects of thyroid hormone on vitamin D-induced nephrocalcinosis. J Pathol. 1973;111(1):13-21.

[2] Verissimo T, Dalga D, Arnoux G, et al. PCK1 is a key regulator of metabolic and mitochondrial functions in renal tubular cells. Am J Physiol Rena Physiol. 2023;324(6):F532-F543.

[3] Tawfik I, Gottschalk B, Jarc A, et al. T3-induced enhancement of mitochondrial Ca²⁺ uptake as a boost for mitochondrial metabolism. Free Radic Biol Med. 2022;181:197-208.

[4] Spahiu L, Jashari H, Mulliqi-Kotori V, Elezi-Rugova B, Merovci B. Hashimoto thyroiditis and nephrocalcinosis in a child with down syndrome. Acta Inform Med. 2016;24(2):143-145.

[5] Morris CA. Williams syndrome. In: Adam MP, Feldman J, Mirzaa GM, et al, eds. GeneReviews^® [Internet]. University of Washington; 1999: 1993-2023.

[6] Jin SJ, Liu M, Long WJ, Luo XP. Diagnosis of a case with Williams-Beuren syndrome with nephrocalcinosis using chromosome microarray analysis. Zhonghua Er Ke Za Zhi. 2016;54(12):941-945.

[7] Kim YM, Cho JH, Kang E, et al. Endocrine dysfunctions in children with Williams-Beuren syndrome. Ann Pediatr Endocrinol Metab. 2016;21(1):15-20.

[8] Karadag S, Gursu M, Aydin Z, et al. Primary hyperoxaluria in an adult presenting with end-stage renal failure together with hypercalcemia and hypothyroidism. Hemodial Int. 2011;15(4):573-576.

RIGHTS & PERMISSIONS

2024 2024 The Authors. Pediatric Discovery published by John Wiley & Sons Australia, Ltd on behalf of Children's Hospital of Chongqing Medical University.